Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Change in Inventory: 2020-2025

Historic Change in Inventory for Journey Medical (DERM) over the last 5 years, with Sep 2025 value amounting to -$1.0 million.

  • Journey Medical's Change in Inventory fell 149.21% to -$1.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $30,000, marking a year-over-year decrease of 96.07%. This contributed to the annual value of $4.2 million for FY2024, which is 206.88% up from last year.
  • According to the latest figures from Q3 2025, Journey Medical's Change in Inventory is -$1.0 million, which was down 390.45% from $356,000 recorded in Q2 2025.
  • Journey Medical's Change in Inventory's 5-year high stood at $12.0 million during Q2 2021, with a 5-year trough of -$2.7 million in Q3 2021.
  • In the last 3 years, Journey Medical's Change in Inventory had a median value of -$881,000 in 2023 and averaged -$212,818.
  • Per our database at Business Quant, Journey Medical's Change in Inventory slumped by 1,223.81% in 2023 and then skyrocketed by 423.11% in 2024.
  • Over the past 5 years, Journey Medical's Change in Inventory (Quarterly) stood at -$1.8 million in 2021, then surged by 38.87% to -$1.1 million in 2022, then grew by 23.62% to -$818,000 in 2023, then soared by 423.11% to $2.6 million in 2024, then slumped by 149.21% to -$1.0 million in 2025.
  • Its last three reported values are -$1.0 million in Q3 2025, $356,000 for Q2 2025, and -$1.9 million during Q1 2025.